(Q31026696)

28 June 2017

1 reference

title

Neurocutaneous syndromes and epilepsy-issues in diagnosis and management (English)

1 reference

28 June 2017

J Helen Cross

1

1 reference

28 June 2017

publication date

1 January 2005

1 reference

28 June 2017

1 reference

28 June 2017

volume

46 Suppl 10

1 reference

28 June 2017

page(s)

17-23

1 reference

Tuberous sclerosis complex: a review of neurological aspects

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

The relation of infantile spasms, tubers, and intelligence in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Autistic spectrum disorders in childhood epilepsy surgery candidates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Psychopathology in children with epilepsy before and after temporal lobe resection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Visual field constriction in 91 Finnish children treated with vigabatrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Surgical treatment for epilepsy in cerebral tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Surgical treatment of epilepsy in tuberous sclerosis: strategies and results in 18 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Epilepsy surgery outcome in children with focal epilepsy due to tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Diffusion-weighted magnetic resonance imaging and identification of the epileptogenic tuber in patients with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-L-tryptophan positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

alpha-[11C]-Methyl-L-tryptophan PET identifies the epileptogenic tuber and correlates with interictal spike frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Long-term outcome of epilepsy surgery in patients with tuberous sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Outcome of Sturge‐Weber syndrome in 52 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Sturge-Weber syndrome: study of 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Sturge-Weber syndrome: correlation between clinical course and FDG PET findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Epidermal nevus syndrome: a neurologic variant with hemimegalencephaly, gyral malformation, mental retardation, seizures, and facial hemihypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Insights into the pathogenesis of cerebral lesions in incontinentia pigmenti

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Recent advances in neurofibromatosis type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Seizures in neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Clinical aspects of neurofibromatosis 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2005.00353.X

10.1111/J.1528-1167.2005.00353.X

21 January 2018

Identifiers

DOI

1 reference

28 June 2017

1 reference